hesperidin has been researched along with Obesity in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 14 (53.85) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, Y; Haseda, A; Hattori, H; Kondo, S; Kumazoe, M; Nakasone, A; Nishihira, J; Shimamoto, Y; Tachibana, H; Yamamoto, M; Yonekura, M; Yoshitomi, R | 1 |
| Akour, A; Al-Tammemi, AB; AlMuhaissen, SA; Alrawashdeh, MN; An, H; Anastasia, L; Apkon, S; Armstrong, WS; Ayala Izurieta, JE; Barnett, K; Bhowmick, S; Biniskos, N; Booka, E; Brown, JC; Buchanan, SW; Campbell, C; Camporeale, A; Cantos, VD; Cao, Z; Chakraborty, RD; Chaturvedi, V; Chen, C; Chen, G; Chen, Y; Chou, PT; Ciconte, G; Colasanti, JA; Collins, LF; Darras, BT; de Carvalho, RM; De Morais, DC; Delegido, J; Dodd, J; Doki, Y; Dunfield, K; Elfring, G; Feng, B; Ferry, VE; Galaviz, KI; García, VJ; Greven, M; Guo, J; Gutierrez, M; Hameed, S; Hippler, M; Huang, JW; Isaac, ME; Ishihara, R; Ishikawa, H; Ito, Y; Jacobson, A; Jalouqa, S; James, TD; Jara Santillán, CA; Jiang, K; Jordan, R; Kampf, JW; Kato, H; Kato, K; Katzmarzyk, PT; Kaviani, A; Kawachi, H; Kawakubo, H; Khansari Nejad, N; Kitagawa, Y; Kojima, T; Kono, K; Koplowitz, B; Kubo, Y; Kuribayashi, S; Lahiri, CD; Lei, H; Leighton, C; Li, J; Liu, G; Lombardi, M; Lu, Y; Luo, Y; Ma, P; Mafa-Attoye, T; Mahmoud, NN; Makhlina, M; Makino, T; Manguso, F; Mano, M; Manso, AP; Marconi, VC; Márquez, CO; Matsubara, H; Matsuda, S; McDonald, CM; Mecarocci, V; Metcalfe, GD; Micaglio, E; Miele, L; Mire, EF; Miyazaki, T; Moi, CT; Moore, CM; Moran, CA; Muto, M; Nemoto, K; Nguyen, ML; Nusair, MB; Ochoa, A; Owen, G; Oyama, T; Palma-Dibb, RG; Pappone, C; Parsons, JA; Pasqualotto, N; Peltz, SW; Pesco Koplowitz, L; Pica, S; Postiglione, WM; Qureshi, M; Rhodes, J; Saeki, H; Sakai, M; Santinelli, V; Santos, C; Shah, NS; Shanahan, JP; Shieh, PB; Sisti, JM; Smith, TW; Sohda, M; Song, Y; Spana, C; Sturla, F; Su, BK; Sumitani, J; Szabo, B; Szymczak, NK; Tabiś, W; Takeuchi, H; Tang, X; Thevathasan, NV; Toh, Y; Tondi, L; Trifillis, P; Tsushima, T; Van Wittenberghe, S; Vicedomini, G; Wang, H; Wang, K; Wang, S; Wang, W; Wang, X; Wang, Y; Wu, F; Wu, X; Yamaji, T; Yamamoto, K; Yamatsuji, T; Yang, L; Yang, S; Yang, WH; Yang, Y; Yoshida, M; Yu, B; Yuan, L; Zabaleta, J; Zhang, C; Zhang, H; Zhang, L; Zhang, X; Zhang, Z; Zheng, WQ; Zheng, YX; Zhou, H; Zhou, J; Zhou, N; Zhu, W | 1 |
| Chen, TC; Ho, YY; Ke, YC; Lin, FH; Lin, JN; Tang, RC; Yang, IH | 1 |
| Rabbani, N; Thornalley, PJ | 1 |
| Banerjee, S; Biswas, S; Chanda, J; Kar, A; Mukherjee, PK; Tiwari, A; Ulrich-Merzenich, G | 1 |
| Le, TT; Urasaki, Y | 1 |
| Li, X; Li, Y; Liang, H; Liu, K; Liu, S; Ma, Z; Wang, Y; Wu, C; Xiao, Y; Yu, J; Zhou, L | 1 |
| Chen, Q; Hu, K; Li, H; Li, W; Shi, J | 1 |
| Akash, MSH; Arafa, EA; Buabeid, MA; Chohan, TA; Jabeen, K; Munawar, SM; Rehman, K; Tariq, M | 1 |
| Gan, Q; Hu, J; Huang, Q; Lou, G; Peng, C; Ran, Q; Sun, J; Wang, J; Xiong, H; Yao, R | 1 |
| Caimari, A; Crescenti, A; Del Bas, JM; Domenech-Coca, C; Escoté, X; Mas-Capdevila, A; Teichenne, J | 1 |
| Liu, H; Lu, JF; Peng, L; Shi, X; Wang, YL; Wu, JW; Xia, B; Zhang, H; Zhu, MQ | 1 |
| Bai, YF; Fan, XY; Lou, LJ; Sheng, H; Wang, SW; Weng, YY; Zhang, F | 1 |
| Kurokawa, M; Sugita, C; Tsuhako, R; Yoshida, H | 1 |
| Rabbani, N; Thornalley, PJ; Weickert, MO; Xue, M | 1 |
| Chen, K; Chen, X; He, Q; Li, X; Liu, Y; Ma, J; Si, M; Sun, C; Wu, H; Yan, Y; Yang, B; Zhu, D | 1 |
| Pu, P | 1 |
| Mosqueda-Solís, A; Palou, A; Picó, C; Portillo, MP; Sánchez, J | 1 |
| Murosaki, S; Muroyama, K; Ohara, T; Yamamoto, Y | 2 |
| Anwar, A; Fowler, M; Jenkins, G; Kandala, NB; Messenger, D; Qureshi, S; Rabbani, N; Shafie, A; Thornalley, PJ; Waldron, M; Weickert, MO; Xue, M | 1 |
| de Groot, E; Garcés-Rimón, M; Masclee, AA; Possemiers, S; Salden, BN; Stevens, YR; Troost, FJ; Winkens, B | 1 |
| Avril, L; Boussetta, S; Enriquez Vega, DM; Guex, JJ; Taïeb, C | 1 |
| Holland, LJ; Jackson, DE; Manthey, JA; Nichols, LA; Shukla, SD | 1 |
| Freuchet, B; Jeusette, I; Le Bloc'h, J; Leray, V; Nguyen, P; Torre, C | 1 |
| Kirienko, AI; Oganov, RG; Savel'ev, VS; Shal'nova, SA; Zolotukhin, IA | 1 |
4 review(s) available for hesperidin and Obesity
| Article | Year |
|---|---|
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes; Black or African American; Bleaching Agents; Body Mass Index; Brugada Syndrome; Carbon; China; Climate Models; Codon, Nonsense; Cohort Studies; Colitis; Colon; COVID-19; Cytokines; Dental Enamel; Dextran Sulfate; Disease Models, Animal; Disease Outbreaks; Dogs; Electrocardiography; Escherichia coli; Esophageal Neoplasms; Female; Follow-Up Studies; Forests; Georgia; Glucosides; Healthy Volunteers; Heart Ventricles; Hesperidin; HIV Infections; Humans; Humidity; Hydrogen Peroxide; Incidence; Influenza, Human; Longitudinal Studies; Magnetic Resonance Imaging, Cine; Male; Melanocortins; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Middle Aged; Muscular Dystrophy, Duchenne; Naphthol AS D Esterase; Naphthols; Neoplasms; Nitrates; Nitrites; Nitrous Oxide; Obesity; Pandemics; Patient Outcome Assessment; Patient Satisfaction; Plants; Prednisolone; Prednisone; Pregnenediones; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Rats; Receptor, Melanocortin, Type 1; Retrospective Studies; Risk Factors; SARS-CoV-2; Seasons; Soil; Stroke Volume; T-Lymphocytes; Telemedicine; Temperature; Tetralogy of Fallot; Tooth Bleaching; Tooth Bleaching Agents; Trees; Urea; White People | 2021 |
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Induction; Glutathione; Glycosylation; Hesperidin; Humans; Insulin Resistance; Lactoylglutathione Lyase; Mice; Molecular Structure; Neoplasms, Experimental; Obesity; Pyruvaldehyde; Resveratrol | 2022 |
Hesperidin: A Therapeutic Agent For Obesity.
Topics: Antioxidants; Diabetes Mellitus, Type 2; Hesperidin; Humans; Hypoglycemic Agents; Obesity | 2019 |
Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Cardiovascular System; Citrus; Dysbiosis; Dyslipidemias; Flavanones; Gastrointestinal Microbiome; Hesperidin; Humans; Obesity; Risk Factors | 2020 |
7 trial(s) available for hesperidin and Obesity
| Article | Year |
|---|---|
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial.
Topics: Adult; Body Mass Index; Catechin; Female; Glucosides; Hesperidin; Humans; Male; Middle Aged; Obesity; Placebos; Tea | 2021 |
Reversal of Insulin Resistance in Overweight and Obese Subjects by
Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glucose Metabolism Disorders; Glycosylation; Hesperidin; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leukocytes, Mononuclear; Male; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Tumor Necrosis Factor-alpha | 2021 |
Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
Topics: Abdominal Fat; Adiposity; Adult; Aged; Anti-Obesity Agents; Body Mass Index; Caffeine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucosides; Hesperidin; Humans; Male; Middle Aged; Obesity; Sensitivity and Specificity; Subcutaneous Fat; Surveys and Questionnaires; Triglycerides; Walking; Young Adult | 2016 |
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Cell Line; Cross-Over Studies; Female; Glutathione; Glutathione Disulfide; Hep G2 Cells; Hesperidin; Humans; Lactoylglutathione Lyase; Male; Middle Aged; Models, Biological; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Stilbenes; Young Adult | 2016 |
Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cell Adhesion Molecules; Dietary Supplements; Double-Blind Method; Down-Regulation; Endothelium, Vascular; Female; Hesperidin; Humans; Male; Middle Aged; Obesity; Overweight; P-Selectin; Postprandial Period; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2016 |
Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment - 'QUALITY Study'.
Topics: Administration, Oral; Adult; Ascorbic Acid; Body Mass Index; Chalcone; Chronic Disease; Drug Therapy, Combination; Female; Hesperidin; Humans; Male; Mexico; Middle Aged; Obesity; Plant Extracts; Prospective Studies; Quality of Life; Ruscus; Surveys and Questionnaires; Vascular Diseases | 2009 |
Effect of citrus polyphenol- and curcumin-supplemented diet on inflammatory state in obese cats.
Topics: Acute-Phase Proteins; Animals; Cat Diseases; Cats; Citrus; Cross-Over Studies; Curcumin; Cytokines; Female; Flavanones; Gene Expression Regulation; Hesperidin; Inflammation; Leukocytes, Mononuclear; Male; Obesity; RNA, Messenger | 2011 |
15 other study(ies) available for hesperidin and Obesity
| Article | Year |
|---|---|
Thiolated Chitosan as an Intestinal Absorption Carrier with Hesperidin Encapsulation for Obesity Treatment.
Topics: Animals; Cells, Cultured; Chitosan; Disulfides; Drug Delivery Systems; Gastrointestinal Tract; Hesperidin; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Male; Mice, Inbred C57BL; Nutrients; Obesity; Thioglycolates | 2021 |
Combining LC-MS/MS profiles with network pharmacology to predict molecular mechanisms of the hyperlipidemic activity of Lagenaria siceraria stand.
Topics: Animals; Atorvastatin; Chromatography, Liquid; Cucurbita; Flavonoids; Glycosides; Hesperidin; Hyperlipidemias; Hypertension; Insulins; Network Pharmacology; Obesity; Plant Extracts; Proto-Oncogene Proteins c-akt; Rats; Tandem Mass Spectrometry | 2023 |
Functional Complementation of Anti-Adipogenic Phytonutrients for Obesity Prevention and Management.
Topics: Adipocytes; Adipogenesis; Animals; Berberine; beta Catenin; Cholesterol; Curcumin; Cytokines; Fatty Acids; Glucose; Hesperidin; Humans; Lipoproteins, LDL; Luteolin; Mice; Obesity; Phytochemicals; PPAR gamma; Quercetin; Resveratrol; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2022 |
Hesperidin methyl chalcone ameliorates lipid metabolic disorders by activating lipase activity and increasing energy metabolism.
Topics: Animals; Chalcones; Energy Metabolism; Flavonoids; Hesperidin; Lipase; Lipid Metabolism Disorders; Lipids; Mice; Obesity | 2023 |
Hesperidin inhibits methylation and autophagy in LPS and high glucose-induced human villous trophoblasts.
Topics: Autophagy; Diabetes, Gestational; Female; Glucose; Hesperidin; Humans; Inflammation; Lipopolysaccharides; Methylation; Molecular Docking Simulation; Obesity; Placenta; Pregnancy; Trophoblasts | 2023 |
Hesperidin improves insulin resistance via down-regulation of inflammatory responses: Biochemical analysis and in silico validation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Hesperidin; Hyperlipidemias; Inflammation; Insulin Resistance; Leptin; Molecular Docking Simulation; Molecular Dynamics Simulation; Obesity; Orlistat; Rats, Wistar | 2020 |
Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice.
Topics: Animals; Bacteroidetes; Diet, High-Fat; Firmicutes; Gastrointestinal Microbiome; Hesperidin; Male; Mice; Obesity | 2020 |
Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Hesperidin; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2020 |
Glucosyl Hesperidin Has an Anti-diabetic Effect in High-Fat Diet-Induced Obese Mice.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Chemokine CCL2; Coculture Techniques; Diet, High-Fat; Disease Models, Animal; Glucosides; Hesperidin; Hyperglycemia; Hypoglycemic Agents; Macrophages; Male; Mice; Mice, Inbred C57BL; Obesity; RAW 264.7 Cells | 2021 |
Neohesperidin Exerts Lipid-Regulating Effects in vitro and in vivo via Fibroblast Growth Factor 21 and AMP-Activated Protein Kinase/Sirtuin Type 1/Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1α Signaling Axis.
Topics: AMP-Activated Protein Kinases; Animals; Body Weight; Dyslipidemias; Fibroblast Growth Factors; Hep G2 Cells; Hesperidin; Humans; Lipid Metabolism; Liver; Mice, Inbred C57BL; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; RNA, Small Interfering; Sirtuin 1 | 2017 |
[Protection mechanisms of hesperidin on mouse with insulin resistance].
Topics: Animals; Blood Glucose; Diet, High-Fat; Hesperidin; Hyperglycemia; Hyperlipidemias; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Signal Transduction | 2016 |
Combination of Capsaicin and Hesperidin Reduces the Effectiveness of Each Compound To Decrease the Adipocyte Size and To Induce Browning Features in Adipose Tissue of Western Diet Fed Rats.
Topics: Adipocytes; Adipose Tissue, White; Animals; Apoptosis Regulatory Proteins; Capsaicin; Cell Size; Color; Diet, Western; Drug Therapy, Combination; Hesperidin; Humans; Male; Obesity; Plant Extracts; Rats; Rats, Wistar; Uncoupling Protein 1 | 2018 |
A combination of glucosyl hesperidin and caffeine exhibits an anti-obesity effect by inhibition of hepatic lipogenesis in mice.
Topics: Adipogenesis; Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Caffeine; Diet, High-Fat; Fatty Acid Synthases; Glucosides; Hesperidin; Lipids; Lipogenesis; Liver; Male; Mice; Mice, Obese; Obesity; Sterol Regulatory Element Binding Protein 1 | 2015 |
Citrus flavonoids repress the mRNA for stearoyl-CoA desaturase, a key enzyme in lipid synthesis and obesity control, in rat primary hepatocytes.
Topics: Animals; Citrus; Enzyme Repression; Flavones; Gene Expression Regulation, Enzymologic; Hepatocytes; Hesperidin; Lipids; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stearoyl-CoA Desaturase | 2011 |
[Risk factors of chronic venous insufficiency of the lower extremities and possibilities of its medication in therapeutic practice].
Topics: Adolescent; Adult; Age Factors; Aged; Bandages; Chronic Disease; Constipation; Diosmin; Drug Combinations; Exercise Therapy; Female; Hesperidin; Humans; Incidence; Leg; Male; Middle Aged; Obesity; Risk Factors; Sex Factors; Treatment Outcome; Venous Insufficiency | 2006 |